Barbara Weir

Title: Barbara Weir: Innovator in Cancer Research

Introduction

Barbara Weir is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of cancer research through her innovative work in targeting cancer-specific DNA sequences. Her dedication to advancing medical science has led to the development of valuable patents that aim to improve cancer treatment.

Latest Patents

Barbara Weir holds a patent for "Compositions and methods for targeting cancer-specific sequence variations." This invention relates to compositions and methods designed to target cancer-specific DNA sequences, including copy number amplifications and other variations such as polymorphisms, insertions, or deletions. The patent provides sequence-specific DNA targeting agents that focus on sequences within the amplified DNA region or those specific to cancer cells compared to non-cancer cells. Additionally, the invention outlines methods for treating cancer by administering these targeting agents, as well as methods for preparing and screening these agents.

Career Highlights

Throughout her career, Barbara Weir has worked with esteemed organizations, including the Broad Institute, Inc. and Dana-Farber Cancer Institute Inc. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Barbara Weir's notable coworkers include William C. Hahn and Andrew J. Aguirre. Their collaborative efforts have further advanced the understanding and treatment of cancer.

Conclusion

Barbara Weir's innovative contributions to cancer research exemplify her commitment to improving patient outcomes through scientific advancements. Her patent and collaborations highlight her role as a key figure in the ongoing fight against cancer.